We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nitrous Oxide Use During Labor Is Safe

By HospiMedica International staff writers
Posted on 09 Jun 2020
A new study suggests that the use of nitrous oxide (N2O) as a pain relief option for women in labor is safe for both newborn child and mother. More...


Researchers at the University of Colorado (CU; Aurora, USA), the Icahn School of Medicine at Mount Sinai (New York, NY, USA), and other institutions conducted a prospective chart review study involving 463 women who used inhaled N2O during the first or second stage of labor, and their neonates. The researchers modeled oxytocin augmentation, labor induction, parity, prior cesarean birth, cervical dilatation, and their effect on the odds of conversion from N2O to neuraxial analgesia, such as an epidural or use of an opioid.

The results showed that 31% of those who chose N2O for analgesia did not convert to any other method. Significant positive predictors for conversion from N2O to neuraxial analgesia included labor induction, oxytocin augmentation (3-fold), and labor after a previous cesarean (6-fold). Multiparity and post‐N2O cervical dilatation were negative predictors. Adverse effects related to N2O were rare (8%) and were not a significant reason for conversion. In addition, five‐minute Apgar scores were 7 or greater in 97.8% of the newborns. The study was published on May 26, 2020, in the Journal of Midwifery & Women's Health.

“Nitrous oxide is a useful, safe option for labor analgesia in the United States. And for some laboring mothers, that's all the pain relief they need,” said lead author Priscilla Nodine, PhD, CNM, of the CU College of Nursing. “Understanding predictors of conversion from inhaled nitrous oxide to other forms of analgesia may assist providers in their discussions with women about pain relief options during labor.”

The exact mechanism of how analgesia from N2O is obtained is not fully understood, but the prevailing theory is that it inhibits excitatory glutamatergic neurotransmission via inhibition of the N-Methyl-D-aspartic acid (NMDA) subtype of glutamate receptors. During labor, N2O is blended 50/50 with oxygen; the woman controls intake with her respiratory efforts by inhaling through a mask containing a demand valve that releases the gas only when she inhales; it may be used throughout all stages of labor.

Related Links:
University of Colorado
Icahn School of Medicine at Mount Sinai



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.